Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003408 | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer | completed | Phase 2 | 40 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00005908 | Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00244959 | Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer | completed | Phase 2 | 54 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00072319 | Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00122369 | Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy | completed | Phase 2 | 240 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00767520 | Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer | completed | Phase 2 | 155 | Bristol-Myers SquibbINDUSTRY | 8 | Feb 28, 2013 | clinicaltrials |
| NCT00077363 | Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00811824 | Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors | completed | Phase 2 | 42 | Columbia UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00049062 | Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00136539 | Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | completed | Phase 2 | 41 | Harold J. Burstein, MD, PhDOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00003796 | Irofulven in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00962494 | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors | completed | Phase 2 | 585 | Stanford UniversityOTHER | 2 | Feb 7, 2013 | clinicaltrials |
| NCT01784393 | Chemoradiation for Bone Metastasis | completed | Phase 2 | 29 | Rabin Medical CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00005817 | Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00050141 | Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer | completed | Phase 2 | 121 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 6 | Feb 1, 2013 | clinicaltrials |
| NCT00534417 | Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer | completed | Phase 2 | 41 | Accelerated Community Oncology Research NetworkOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00003041 | Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00003068 | High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer | completed | Phase 2 | 30 | University of ArizonaOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00645177 | Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer | completed | Phase 2 | 10 | AbbVie (prior sponsor, Abbott)INDUSTRY | 2 | Jan 29, 2013 | clinicaltrials |
| NCT00003953 | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | 39 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00015938 | S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 95 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00024154 | Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 132 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00098397 | FR901228 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00025584 | PS-341 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00045188 | Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00967031 | Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases | completed | Phase 2 | 45 | UNICANCEROTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00017394 | Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00059943 | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00540358 | A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer | completed | Phase 2 | 123 | SanofiINDUSTRY | 1 | Dec 28, 2012 | clinicaltrials |
| NCT00981864 | Concurrent Boost Radiotherapy | completed | Phase 2 | 17 | University Health Network, TorontoOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00416403 | Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer | completed | Phase 2 | 35 | University of California, San FranciscoOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00003352 | Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer | completed | Phase 2 | 89 | NSABP Foundation IncNETWORK | 3 | Dec 11, 2012 | clinicaltrials |
| NCT00429104 | Herceptin and GM-CSF for Metastatic Breast Cancer | completed | Phase 2 | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00586326 | MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ(DCIS) | completed | Phase 2 | 133 | Hologic, Inc.INDUSTRY | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00212095 | Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer | completed | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00005798 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer(CTC) | completed | Phase 2 | 209 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00148070 | Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 45 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00007904 | Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | completed | Phase 2 | 16 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00636467 | Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm(GAS2PLUS) | completed | Phase 2 | 249 | Centre Leon BerardOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | completed | Phase 2 | 45 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT01044485 | Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer(LapDoc) | completed | Phase 1 / Phase 2 | 17 | Centre Georges Francois LeclercOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00028977 | Herbal Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 21 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00633750 | Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery | completed | Phase 2 | 50 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 5, 2012 | clinicaltrials |
| NCT01190982 | Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer | completed | Phase 2 | 70 | INSYS Therapeutics IncINDUSTRY | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00364611 | Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer | completed | Phase 2 | 73 | SanofiINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00232479 | Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer | completed | Phase 2 | 48 | University of MiamiOTHER | 1 | Aug 21, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Mar 26, 2013source: clinicaltrials